Spencer Pharmaceutical Inc. Announces Securities Awareness Campaign
BOSTON, MA--(Marketwire - June 8, 2010) - Spencer Pharmaceutical Inc. (
According to management of Spencer Pharmaceutical Inc. (the "Company"), a Securities Awareness Campaign is not unlike an advertising campaign in that, it is a series of advertisements and/or sponsored messages that share a single idea and theme to create awareness of a company's current business and future objectives and potential.
A securities awareness campaign may include the hiring of investor relations personnel, launching a new web-based investor relations platform, engaging third parties to send emails to opt-in subscribers of newsletters and/or information websites, placing ads on websites, sponsoring research reports, interacting on message boards and mailing press kits and information. These services can be paid and or hired by the Company with the issuance of restricted shares and/or cash. It is also possible that existing shareholders may pay individuals and/or companies to perform these services and these shareholders could pay with the transfer of their own shares and/or cash (with no compensation by the Company). In the case of any services compensation by the Company, the Company, as a condition to providing any service, require a discloser of said payment and or hiring.
Shareholders and/or potential shareholders should be aware that a securities awareness campaign does not guarantee that a market will develop in the Company's securities and that in the event an active market does develop, the price of the stock may not reflect the fundamental value of the Company. It should be further noted that the shares are tightly held by few shareholders and this may have the result of a sudden increase in the price of the security and the same is true if the security is sold, it may result in a sudden drop in price of the stock.
The Company does not support in any way the use of "spamming" and request that shareholders immediately contact the company in the event they receive said or are aware of such activity.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic syndrome diseases including diabetes.
Important Information
About Forward-Looking Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.